# FDA recall D-0384-2022

> **Dr. Reddy's Laboratories, Inc.** · Class III · drug recall initiated 2022-01-04.

## Product

QC QUALITY CHOICE, Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg, Extended-Release Tablets, USP,  Allergy & Congestion, 10 Tablets per box, NDC 63868-729-10, Distributed by C.D.M.A., Inc., 43157 W 9 Mile Rd, Novi, MI 48375, Made in India.

## Reason for recall

Failed Dissolution Specifications

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0384-2022
- **Recalling firm:** Dr. Reddy's Laboratories, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-01-04
- **Report date:** 2022-01-26
- **Termination date:** 2023-10-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0384-2022

## Citation

> AI Analytics. FDA recall D-0384-2022. Retrieved 2026-06-10 from https://api.ai-analytics.org/recall/D-0384-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*